• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清骨桥蛋白是否可预测现患血液透析患者颈动脉粥样硬化严重程度?

Is serum Osteopontin a predictor of carotid atherosclerosis severity among prevalent hemodialysis patients?

机构信息

Internal Medicine and Nephrology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Internal Medicine and Nephrology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

出版信息

Clin Investig Arterioscler. 2022 Mar-Apr;34(2):75-85. doi: 10.1016/j.arteri.2021.11.004. Epub 2022 Feb 8.

DOI:10.1016/j.arteri.2021.11.004
PMID:35144845
Abstract

BACKGROUND AND AIM

Chronic hemodialysis (HD) patients are among the highest population risk for accelerated atherosclerosis. Osteopontin (OPN) is a multifunctional protein that is increased in chronic kidney disease that may play a role in vascular remodelling and intimal proliferation.

AIM

To assess the relation between OPN levels and severity of carotid atherosclerosis among prevalent HD patients.

METHODS

Eighty chronic HD patients underwent serum OPN levels assessment and were further classified into 3 subgroups according to the OPN tertiles' levels; sub-group 1 (lower tertile) subgroup 2 (middle tertile) and sub-group 3 (upper tertile), together with the carotid duplex and Transthoracic Doppler Echocardiography examination.

RESULTS

The mean carotid intima-media thickness (CIMT) was 0.89±0.14mm. Out of the studied group, 50 (62.5%) patients had atheromatous plaques and 15 patients (18.8%). had significant stenosis. The 3rd group with the upper OPN tertile (78-270ng/dl) had the highest incidence of atherosclerosis. A significant correlation between the OPN levels and the CIMT (r=0.533, p=0.001). OPN values detect atherosclerosis with diagnostic sensitivity of 70%, specificity of 69%, positive predictive value (PPV) 73%, negative predictive value (NPV) 65% with area under the curve (AUC) 0.804 (95% CI: 0.711-0.897). Serum OPN detect carotid stenosis with sensitivity of 66%, specificity of 81%, PPV 45%, NPV 91% with AUC=0.769 and detect the presence of carotid atheroma with sensitivity 70%, specificity 66.67%, PPV 77.8%, NPV 57.1% and AUC=0.767 (p-value<0.001). Moreover, serum levels of OPN were significantly positively correlated with grade of diastolic dysfunction (r=0.312, p=0.005), E/A ratio (r=0.293, p=0.008) and inversely correlated with left ventricular ejection fraction (r=-0.304, p=0.006).

CONCLUSIONS

Serum Osteopontin is of clinical value as a predictor biomarker of the severity of carotid atherosclerosis, presence of atheroma and carotid stenosis with high diagnostic sensitivity and specificity in chronic hemodialysis patients. Increased Osteopontin level is associated with left ventricular diastolic and systolic dysfunction in those patients.

摘要

背景与目的

慢性血液透析(HD)患者是发生动脉粥样硬化加速的最高危人群之一。骨桥蛋白(OPN)是一种在慢性肾脏病中增加的多功能蛋白,可能在血管重塑和内膜增殖中发挥作用。

目的

评估在现患 HD 患者中 OPN 水平与颈动脉粥样硬化严重程度之间的关系。

方法

80 名慢性 HD 患者接受血清 OPN 水平评估,并根据 OPN 三分位水平进一步分为 3 个亚组;亚组 1(低三分位)、亚组 2(中三分位)和亚组 3(高三分位),同时进行颈动脉双功超声和经胸多普勒超声心动图检查。

结果

颈动脉内膜中层厚度(CIMT)的平均值为 0.89±0.14mm。在研究组中,50 名(62.5%)患者有动脉粥样硬化斑块,15 名(18.8%)患者有显著狭窄。OPN 三分位的第 3 组(78-270ng/dl)的动脉粥样硬化发生率最高。OPN 水平与 CIMT 呈显著正相关(r=0.533,p=0.001)。OPN 值检测动脉粥样硬化的诊断灵敏度为 70%,特异性为 69%,阳性预测值(PPV)为 73%,阴性预测值(NPV)为 65%,曲线下面积(AUC)为 0.804(95%CI:0.711-0.897)。血清 OPN 检测颈动脉狭窄的灵敏度为 66%,特异性为 81%,PPV 为 45%,NPV 为 91%,AUC=0.769,检测颈动脉粥样硬化的灵敏度为 70%,特异性为 66.67%,PPV 为 77.8%,NPV 为 57.1%,AUC=0.767(p 值<0.001)。此外,血清 OPN 水平与舒张功能不全程度呈显著正相关(r=0.312,p=0.005),与 E/A 比值呈显著正相关(r=0.293,p=0.008),与左心室射血分数呈显著负相关(r=-0.304,p=0.006)。

结论

血清骨桥蛋白作为预测标志物,在慢性血液透析患者中具有预测颈动脉粥样硬化严重程度、存在动脉粥样硬化和颈动脉狭窄的临床价值,具有较高的诊断灵敏度和特异性。OPN 水平升高与左心室舒张和收缩功能障碍有关。

相似文献

1
Is serum Osteopontin a predictor of carotid atherosclerosis severity among prevalent hemodialysis patients?血清骨桥蛋白是否可预测现患血液透析患者颈动脉粥样硬化严重程度?
Clin Investig Arterioscler. 2022 Mar-Apr;34(2):75-85. doi: 10.1016/j.arteri.2021.11.004. Epub 2022 Feb 8.
2
Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus.在系统性红斑狼疮的特征明确的患者中,血浆骨桥蛋白与颈总动脉内膜中层厚度的关系。
Lupus. 2021 Jul;30(8):1244-1253. doi: 10.1177/09612033211013898. Epub 2021 May 6.
3
Serum osteopontin negatively impacts on intima-media thickness in patients with systemic lupus erythematosus.血清骨桥蛋白对系统性红斑狼疮患者的内中膜厚度有负面影响。
Eur J Clin Invest. 2019 May;49(5):e13089. doi: 10.1111/eci.13089. Epub 2019 Mar 3.
4
The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.血清血管钙化抑制剂水平与颈动脉斑块易损性之间的关系。
J Vasc Surg. 2008 Jan;47(1):55-62. doi: 10.1016/j.jvs.2007.09.058.
5
Serum levels of osteopontin predict major adverse cardiovascular events in patients with severe carotid artery stenosis.骨桥蛋白血清水平可预测严重颈动脉狭窄患者的主要不良心血管事件。
Int J Cardiol. 2018 Mar 15;255:195-199. doi: 10.1016/j.ijcard.2018.01.008. Epub 2018 Jan 5.
6
Osteopontin and carotid atherosclerosis in patients with essential hypertension.原发性高血压患者骨桥蛋白与颈动脉粥样硬化
Clin Sci (Lond). 2006 Nov;111(5):319-24. doi: 10.1042/CS20060074.
7
Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.强化降脂比适度降脂治疗更能稳定颈动脉斑块。
J Vasc Surg. 2010 Jan;51(1):114-21. doi: 10.1016/j.jvs.2009.07.119. Epub 2009 Oct 17.
8
Carotid artery atherosclerotic profile as a predictor of the aorta atherosclerotic profile in patients with cerebrovascular events.颈动脉粥样硬化特征可预测脑血管事件患者的主动脉粥样硬化特征。
Cerebrovasc Dis. 2013;36(1):26-32. doi: 10.1159/000351150. Epub 2013 Jul 30.
9
Differences in cardiovascular disease risk factors associated with maximum and mean carotid intima-media thickness among hemodialysis patients.血液透析患者中与最大颈动脉内膜中层厚度和平均颈动脉内膜中层厚度相关的心血管疾病危险因素差异。
Iran J Kidney Dis. 2012 May;6(3):203-8.
10
Expression of NPP1 is regulated during atheromatous plaque calcification.NPP1 的表达在动脉粥样硬化斑块钙化过程中受到调节。
J Cell Mol Med. 2011 Feb;15(2):220-31. doi: 10.1111/j.1582-4934.2009.00988.x.

引用本文的文献

1
The Role of Osteopontin in Atherosclerosis and Its Clinical Manifestations (Atherosclerotic Cardiovascular Diseases)-A Narrative Review.骨桥蛋白在动脉粥样硬化及其临床表现(动脉粥样硬化性心血管疾病)中的作用——一项叙述性综述
Biomedicines. 2023 Nov 29;11(12):3178. doi: 10.3390/biomedicines11123178.
2
Association of serum levels of osteopontin and osteoprotegerin with adverse outcomes after endovascular revascularisation in peripheral artery disease.血清骨桥蛋白和护骨素水平与外周动脉疾病血管内再通后不良结局的关系。
Cardiovasc Diabetol. 2022 Sep 1;21(1):171. doi: 10.1186/s12933-022-01605-6.